Repligen
RGEN
#1859
Rank
$11.09 B
Marketcap
$173.49
Share price
2.97%
Change (1 day)
19.11%
Change (1 year)
Categories

Repligen (RGEN) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : $0.83 Billion USD

According to Repligen 's latest financial reports the company's total liabilities are $0.83 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Repligen - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31$0.85 B38.97%
2022-12-31$0.61 B0.93%
2021-12-31$0.60 B62.76%
2020-12-31$0.37 B9.81%
2019-12-31$0.34 B113.98%
2018-12-31$0.15 B4.66%
2017-12-31$0.15 B26.49%
2016-12-31$0.12 B411.51%
2015-12-31$23.48 M41.83%
2014-12-31$16.56 M12.21%
2013-12-31$14.75 M14.54%
2012-12-31$12.88 M
2011-03-31$5.2 M-1.74%
2010-03-31$5.29 M14.43%
2009-03-31$4.63 M-2.15%
2008-03-31$4.73 M33.79%
2007-03-31$3.53 M11.73%
2006-03-31$3.16 M-4.56%
2005-03-31$3.31 M35.36%
2004-03-31$2.45 M9.25%
2003-03-31$2.24 M-15.88%
2002-03-31$2.66 M112.18%
2001-03-31$1.25 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
$115.63 B 13,696.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
$60.36 B 7,102.31%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
$109.44 B 12,957.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$65.36 B 7,699.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
$78.92 M-90.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
$1.14 B 36.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
$1.66 B 98.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
$0.47 B-42.91%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$5.40 B 544.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
$4.64 B 454.03%๐Ÿ‡บ๐Ÿ‡ธ USA